Canopy Growth Corporation (TSX:WEED)
1.380
-0.040 (-2.82%)
Jun 30, 2026, 4:00 PM EST
Canopy Growth Revenue
In the fiscal year ending March 31, 2026, Canopy Growth had annual revenue of 284.60M CAD with 5.80% growth. Canopy Growth had revenue of 71.25M in the quarter ending March 31, 2026, with 9.56% growth.
Revenue
284.60M
Revenue Growth
+5.80%
P/S Ratio
2.05
Revenue / Employee
252.31K
Employees
1,128
Market Cap
582.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 284.60M | 15.61M | 5.80% |
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
| Mar 31, 2019 | 226.34M | 148.39M | 190.37% |
| Mar 31, 2018 | 77.95M | 38.05M | 95.38% |
| Mar 31, 2017 | 39.90M | 27.20M | 214.16% |
| Mar 31, 2016 | 12.70M | 10.33M | 435.60% |
| Mar 31, 2015 | 2.37M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.14B |
| Cresco Labs | 895.33M |
| Knight Therapeutics | 510.45M |
| TerrAscend | 365.43M |
| Aurora Cannabis | 320.59M |
| DRI Healthcare Trust | 275.45M |
| Organigram Global | 274.19M |
| Cronos Group | 222.69M |
Canopy Growth News
- 3 days ago - Canopy Growth's Medical Marijuana Sales Are Soaring. Is the Beaten-Down Stock Ready to Rebound? - The Motley Fool
- 8 days ago - Leading Canadian Marijuana Stocks Showing Momentum in 2026 - MarijuanaStocks
- 13 days ago - 3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year - MarijuanaStocks
- 15 days ago - Canopy Growth price target lowered to C$1.60 from C$1.80 at Alliance Global - TheFly
- 15 days ago - CGC Q4 Earnings Call Focuses on EBITDA Path - Nasdaq
- 15 days ago - Where Will Canopy Growth Be in 5 Years? - The Motley Fool
- 15 days ago - Canopy Growth Corporation (WEED:CA) Reports Q4 Fiscal 2026 Results and Strategic Initiatives - GuruFocus
- 15 days ago - Canopy Growth Reports 300.0% Wider Q4 2026 Loss at -$0.40/Share - AlphaStreet